SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001231919-24-000064
Filing Date
2024-08-09
Accepted
2024-08-09 16:39:24
Documents
1
Effectiveness Date
2024-08-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11606
  Complete submission text file 0001231919-24-000064.txt   12960
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-521145 | Film No.: 241193430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)